Medtronic plc Stock

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
81.37 USD +0.96% Intraday chart for Medtronic plc -1.12% -1.23%
Sales 2024 32.36B Sales 2025 * 33.42B Capitalization 107B
Net income 2024 3.68B Net income 2025 * 4.93B EV / Sales 2024 4.01 x
Net Debt 2024 23.74B Net Debt 2025 * 20.36B EV / Sales 2025 * 3.8 x
P/E ratio 2024
28.9 x
P/E ratio 2025 *
22.4 x
Employees 95,000
Yield 2024
3.51%
Yield 2025 *
3.37%
Free-Float 99.78%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.21%
1 week-1.12%
1 month+1.41%
3 months-2.39%
6 months+2.65%
Current year-1.23%
More quotes
1 week
80.46
Extreme 80.46
82.74
1 month
80.13
Extreme 80.13
86.17
Current year
78.43
Extreme 78.43
89.18
1 year
68.84
Extreme 68.84
91.00
3 years
68.84
Extreme 68.84
135.89
5 years
68.84
Extreme 68.84
135.89
10 years
55.54
Extreme 55.54
135.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 15-01-25
Director of Finance/CFO 58 16-05-31
Chief Operating Officer 63 21-03-31
Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 70 06-12-31
Director/Board Member 68 14-12-31
More insiders
Date Price Change Volume
24-05-31 81.37 +0.96% 11,406,030
24-05-30 80.6 -1.09% 8,871,618
24-05-29 81.49 -0.62% 7,910,489
24-05-28 82 -0.35% 7,478,985
24-05-24 82.29 +1.12% 8,732,273

Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT

More quotes
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
81.37 USD
Average target price
94.07 USD
Spread / Average Target
+15.61%
Consensus